aap: LOQTEQ® VA Distal Radius System has clinically proven and receives high level of market acceptance
(Thomson Reuters ONE) -
aap Implantate AG /
aap: LOQTEQ® VA Distal Radius System has clinically proven and receives high
level of market acceptance
. Processed and transmitted by Nasdaq Corporate Solutions.
The issuer is solely responsible for the content of this announcement.
* First polyaxial system in LOQTEQ® product family since one year successful
in the market
The evaluation following the market launch one year ago shows that the LOQTEQ®
VA Distal Radius System 2.5 from aap Implantate AG ("aap") has clinically proven
and enjoys a high level of market acceptance. Both the implant and the related
instruments meet with a positive response by users and customers. The LOQTEQ® VA
Distal Radius System 2.5 is the first product in the LOQTEQ® VA (VA = Variable
Angle) product family, which are polyaxial implants that facilitate inserting
angle-stable screws at different angles. Polyaxial implants are required for
treating areas such as the hand that in surgery require both angle stability and
flexibility in the insertion of screws.
The LOQTEQ® VA Distal Radius System 2.5 was developed for the treatment of
fractures of the distal radius (radius close to the wrist) and the distal ulna
(ulna close to the wrist). Radius fractures account for about a quarter of all
fractures. To meet patients' growing demands, a fast, mobilization-stable
treatment with a permanent retention of the repositioning result is required.
The special combination of anatomically preformed and small, angle-stable plates
in conjunction with freely selectable screw angles and user-friendly instruments
fulfils all the requirements of modern fracture management.
After already granted FDA approval the polyaxial radius system has been in use
in the USA since this year as well and receives an especially high acceptance
there. A sterilizing and a sieve system were developed specially for the U.S.
market. Overall the wide range of plates in a compact set and specially
developed instruments such as the screwdriver, co-designed by users, meet with a
positive response. As radius fractures belong to the most frequent fractures the
system is a sales driver. aap will shortly be launching further polyaxial
variants of different LOQTEQ® products for various anatomical areas in the
market.
About aap Implantate AG
aap Implantate AG is a globally operating medical device company headquartered
in Berlin, Germany. The company develops, manufactures and markets trauma
products for orthopaedics. The IP protected portfolio includes besides the
innovative anatomical plating system LOQTEQ® and trauma complementary
biomaterials a wide range of cannulated screws as well as standard plates and
screws. Furthermore, aap Implantate AG has an innovation pipeline with promising
development projects as the antibacterial silver coating technology and
magnesium based implants. These technologies address critical problems in
surgery that haven't yet been resolved adequately. In German-speaking Europe aap
Implantate AG directly sells its products to hospitals, buying syndicates and
hospital groups while it uses a broad network of distributors in more than 25
countries at the international level. aap Implantate AG's stock is listed in the
Prime Standard segment of Frankfurt Stock Exchange (XETRA: AAQ.DE). For more
information, please visit www.aap.de, or download the Company's investor
relations app from the Apple's App Store or Google Play.
Forward-looking statement
This release may contain forward-looking statements based on current experience,
estimates and projections of the management board and currently available
information. They are not guarantees of future performance. Various known and
unknown risks, uncertainties and other factors could lead to material
differences between the actual future results, financial situation, development
or performance of the company and the estimates given here. Many factors could
cause the actual results, performance or achievements of aap to be materially
different from those that may be expressed or implied by such statements. These
factors include those discussed in aap's public reports. Forward-looking
statements therefore speak only as of the date they are made. aap does not
assume any obligation to update the forward-looking statements contained in this
release or to conform them to future events or developments.
For inquiries please contact: aap Implantate AG, Fabian Franke, Investor
Relations, Lorenzweg 5, 12099 Berlin, Germany
Tel.: +49 30 7501 9-134, fax: +49 30 7501 9-290, e-mail: f.franke(at)aap.de
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: aap Implantate AG via GlobeNewswire
Unternehmensinformation / Kurzprofil:
Datum: 18.10.2016 - 13:15 Uhr
Sprache: Deutsch
News-ID 501218
Anzahl Zeichen: 5519
contact information:
Town:
Berlin
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 203 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"aap: LOQTEQ® VA Distal Radius System has clinically proven and receives high level of market acceptance"
steht unter der journalistisch-redaktionellen Verantwortung von
aap Implantate AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
